Author

Erica Loddo

HIGH IL12 AND TH1-RESTRICTED IL23 RECEPTOR EXPRESSION IN THE INTESTINAL LAMINA PROPRIA CELLS IDENTIFIES CROHN’S DISEASE PATIENT’S RESPONDER TO USTEKINUMAB
HIGH IL12 AND TH1-RESTRICTED IL23 RECEPTOR EXPRESSION IN THE INTESTINAL LAMINA PROPRIA CELLS IDENTIFIES CROHN’S DISEASE PATIENT’S RESPONDER TO USTEKINUMAB

Erica Loddo  et al.

CROHN’S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS
CROHN’S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

Erica Loddo  et al.

Item 1 - 2 / 2
1